8-K
Current Report
Lineage Cell Therapeutics, Inc. Filed Acc 0000891092-04-005313
Executive or director change
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading e19584_8k.txt…